Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floxuridine HAI in Colorectal Cancer Liver Metastases
NCT03500874Phase 3Terminated
- Sponsor
- Sun Yat-sen University
- Start
- May 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of floxuridine in Colorectal cancer with liver metastases (CRLM), sponsored by Sun Yat-sen University. Started May 2018; status: terminated.
02
Drugs
floxuridine
03
Conditions
Colorectal cancer with liver metastases (CRLM)
Beyond the preview
Go deeper on NCT03500874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500874.